Hims & Hers Health shares are trading higher after Needham initiated coverage on the stock with a Buy rating and announced a price target of $24.
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health shares rose following Needham's initiation of coverage with a Buy rating and a $24 price target.

August 22, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health shares increased after Needham initiated coverage with a Buy rating and set a price target of $24.
The initiation of coverage by Needham with a Buy rating and a specific price target of $24 is a positive signal to investors, likely leading to increased buying interest and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100